Suchergebnisse
Suchergebnisse:
Tasuku Honjo ist ein japanischer Immunologe, der für Forschungen über die molekularbiologischen Ursachen der Antikörper-Diversität und neue immunologische Ansätze in der Krebstherapie bekannt ist. 2018 wurde ihm zusammen mit James P. Allison der Nobelpreis für Physiologie oder Medizin zuerkannt.
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1).
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"
Tasuku Honjo. The Nobel Prize in Physiology or Medicine 2018. Born: 27 January 1942, Kyoto, Japan. Affiliation at the time of the award: Kyoto University, Kyoto, Japan. Prize motivation: “for their discovery of cancer therapy by inhibition of negative immune regulation”. Prize share: 1/2.
Tasuku Honjo is a distinguished professor and deputy director-general of KUIAS, and a Nobel laureate in medicine for his discovery of PD-1. He has also made significant contributions to molecular immunology, class switch recombination, and cancer immunotherapy.
1. Okt. 2018 · Press release. 2018-10-01. The Nobel Assembly at Karolinska Institutet. has today decided to award. the 2018 Nobel Prize in Physiology or Medicine. jointly to. James P. Allison and Tasuku Honjo. for their discovery of cancer therapy by inhibition of negative immune regulation.
1. Okt. 2018 · Tasuku Honjo and James Allison share the 2018 Nobel Prize in Physiology or Medicine for discovering how to unleash the immune system to attack cancer cells. They studied different proteins that act as brakes on T cells, leading to the development of drugs that have extended survival in some patients.
